Cargando…
Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
Activation of co-stimulatory pathways in cytotoxic T lymphocytes expressing chimeric antigen receptors (CARs) have proven to boost effector activity, tumor rejection and long-term T cell persistence. When using antigen-specific T cell receptors (TCR) instead of CARs, the lack of co-stimulatory signa...
Autores principales: | Olguín-Contreras, Luis Felipe, Mendler, Anna N., Popowicz, Grzegorz, Hu, Bin, Noessner, Elfriede |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666660/ https://www.ncbi.nlm.nih.gov/pubmed/34912334 http://dx.doi.org/10.3389/fimmu.2021.750478 |
Ejemplares similares
-
Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014) -
Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012) -
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
por: Muller, Yannick D., et al.
Publicado: (2021) -
Tumor Lactic Acidosis: Protecting Tumor by Inhibiting Cytotoxic Activity Through Motility Arrest and Bioenergetic Silencing
por: Fischbeck, Angelika J., et al.
Publicado: (2020) -
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells
por: Guercio, Marika, et al.
Publicado: (2020)